New Clinical Guidelines on COVID-19 Published for Haematology and Oncology
A group of senior specialist physicians from Australia and New Zealand – including ALLG Member haematologists as well as oncologists and infectious disease physicians – have published new clinical guidelines for helping people living with cancer in the Medical Journal of Australia.
In “Managing haematology and oncology patients during the COVID-19 pandemic: Interim consensus guidance” (Medical Journal of Australia, 20 March 2020), Dr Robert Weinkove and co-authors have provided advice for clinicians and their healthcare teams to help their patients and support initiatives to contain, delay and prevent the spread of COVID-19.
These guidelines have been endorsed by multiple organisations, including the Australasian Leukaemia & Lymphoma Group (ALLG), the Haematology Society of Australia & New Zealand (HSANZ) and the Bone Marrow Transplant Society of Australia & New Zealand among many others.
The guidance will be updated regularly over the coming weeks and months, and the ALLG will update its supporting materials and notices accordingly.
The ALLG, with the support of its Consumer Representative Panel, several clinician co-authors and numerous cancer organisations led by the Cancer Council of Australia, has produced a companion information sheet regarding the new clinical guidance on COVID-19 for cancer patients, families and carers. The companion guide summarises the key messages from the publication and provides details where patients, family and carers can access support programs and resources from national and state/territory governments as well as cancer charities.